LY 3009120 (BioDeep_00000017082)
代谢物信息卡片
化学式: C23H29FN6O (424.23867559999997)
中文名称: LY3009120
谱图信息:
最多检出来源 () 0%
分子结构信息
SMILES: CC1=CC(=C(C=C1C2=C(N=C3C(=C2)C=NC(=N3)NC)C)NC(=O)NCCC(C)(C)C)F
InChI: InChI=1S/C23H29FN6O/c1-13-9-18(24)19(29-22(31)26-8-7-23(3,4)5)11-16(13)17-10-15-12-27-21(25-6)30-20(15)28-14(17)2/h9-12H,7-8H2,1-6H3,(H2,26,29,31)(H,25,27,28,30)
描述信息
C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor
C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C61074 - Serine/Threonine Kinase Inhibitor
C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C2336 - Raf Kinase Inhibitor
C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor
LY3009120 (DP-4978) is a pan RAF inhibitor which inhibits BRAFV600E, BRAFWT and CRAFWT with IC50s of 5.8, 9.1 and 15 nM, respectively.
同义名列表
数据库引用编号
6 个数据库交叉引用编号
- ChEBI: CHEBI:167662
- KEGG: C72761
- PubChem: 71721540
- ChEMBL: CHEMBL3577124
- CAS: 1454682-72-4
- medchemexpress: HY-12558
分类词条
相关代谢途径
Reactome(0)
BioCyc(0)
PlantCyc(0)
代谢反应
0 个相关的代谢反应过程信息。
Reactome(0)
BioCyc(0)
WikiPathways(0)
Plant Reactome(0)
INOH(0)
PlantCyc(0)
COVID-19 Disease Map(0)
PathBank(0)
PharmGKB(0)
0 个相关的物种来源信息
在这里通过桑基图来展示出与当前的这个代谢物在我们的BioDeep知识库中具有相关联信息的其他代谢物。在这里进行关联的信息来源主要有：
- PubMed: 来源于PubMed文献库中的文献信息，我们通过自然语言数据挖掘得到的在同一篇文献中被同时提及的相关代谢物列表，这个列表按照代谢物同时出现的文献数量降序排序，取前10个代谢物作为相关研究中关联性很高的代谢物集合展示在桑基图中。
- NCBI Taxonomy: 通过文献数据挖掘，得到的代谢物物种来源信息关联。这个关联信息同样按照出现的次数降序排序，取前10个代谢物作为高关联度的代谢物集合展示在桑吉图上。
- Chemical Taxonomy: 在物质分类上处于同一个分类集合中的其他代谢物
- Chemical Reaction: 在化学反应过程中，存在为当前代谢物相关联的生化反应过程中的反应底物或者反应产物的关联代谢物信息。
点击图上的相关代谢物的名称，可以跳转到相关代谢物的信息页面。
文献列表
- Ryan J Sullivan, Antoine Hollebecque, Keith T Flaherty, Geoffrey I Shapiro, Jordi Rodon Ahnert, Michael J Millward, Wei Zhang, Ling Gao, Amanda Sykes, Melinda D Willard, Danni Yu, Andrew E Schade, KrisAnne Crowe, Daniel L Flynn, Michael D Kaufman, James R Henry, Sheng-Bin Peng, Karim A Benhadji, Ilaria Conti, Michael S Gordon, Ramon V Tiu, David S Hong. A Phase I Study of LY3009120, a Pan-RAF Inhibitor, in Patients with Advanced or Metastatic Cancer.
Molecular cancer therapeutics.
2020 02; 19(2):460-467. doi:
10.1158/1535-7163.mct-19-0681. [PMID: 31645440] - Gautham Gampa, Minjee Kim, Afroz S Mohammad, Karen E Parrish, Ann C Mladek, Jann N Sarkaria, William F Elmquist. Brain Distribution and Active Efflux of Three panRAF Inhibitors: Considerations in the Treatment of Melanoma Brain Metastases.
The Journal of pharmacology and experimental therapeutics.
2019 03; 368(3):446-461. doi:
10.1124/jpet.118.253708. [PMID: 30622172] - Su-Min Yang, Yu-Kyoung Park, Jee In Kim, Yun-Han Lee, Tae-Yun Lee, Byeong-Churl Jang. LY3009120, a pan-Raf kinase inhibitor, inhibits adipogenesis of 3T3-L1 cells by controlling the expression and phosphorylation of C/EBP-α, PPAR-γ, STAT‑3, FAS, ACC, perilipin A, and AMPK.
International journal of molecular medicine.
2018 Dec; 42(6):3477-3484. doi:
10.3892/ijmm.2018.3890. [PMID: 30272260] - Xiao Zhao, Xiuchao Wang, Lijun Fang, Chungen Lan, Xiaowei Zheng, Yongwei Wang, Yinlong Zhang, Xuexiang Han, Shaoli Liu, Keman Cheng, Ying Zhao, Jian Shi, Jiayi Guo, Jihui Hao, He Ren, Guangjun Nie. A combinatorial strategy using YAP and pan-RAF inhibitors for treating KRAS-mutant pancreatic cancer.
Cancer letters.
2017 08; 402(?):61-70. doi:
10.1016/j.canlet.2017.05.015. [PMID: 28576749]